Finance

Lists
ZYDUSLIFE:NSE
Zydus Lifesciences Ltd
1 123,00 ₹
-1,51%
(-17,20) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSLIFE...
Open
1 140,10 ₹
High
1 146,50 ₹
Low
1 123,00 ₹
Mkt. cap
1,12 տրլն
Avg. vol.
1,42 մլն
Volume
1,60 մլն
Dividend
0,09%
Quarterly dividend
0,25 ₹
Ex-dividend date
24 հլս, 2026 թ.
P/E ratio
25,03
52-wk high
1 232,10 ₹
52-wk low
835,50 ₹
EPS
44,87 ₹
No. of employees
30 հզր
Open
1 140,10 ₹
High
1 146,50 ₹
Low
1 123,00 ₹
Mkt. cap
1,12 տրլն
Avg. vol.
1,42 մլն
Volume
1,60 մլն
Dividend
0,09%
Quarterly dividend
0,25 ₹
Ex-dividend date
24 հլս, 2026 թ.
P/E ratio
25,03
52-wk high
1 232,10 ₹
52-wk low
835,50 ₹
EPS
44,87 ₹
No. of employees
30 հզր
News stories
From web sources and news partners
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd
CEO-
Employees30 հզր
Founded1952
Headquarters-
Sector-
Last report
11 օգս, 2026 թ.
Fiscal period
Q1 2027
9,48 ₹ / 11,15 ₹
-14,98%miss
Revenue / Est. (INR)
80,17 մլրդ / 76,87 մլրդ
+4,30%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
61,23 մլրդ
68,64 մլրդ
75,87 մլրդ
80,17 մլրդ
Cost of goods sold
16,90 մլրդ
18,36 մլրդ
22,07 մլրդ
22,40 մլրդ
Cost of revenue
16,90 մլրդ
18,36 մլրդ
22,07 մլրդ
22,40 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,34 մլրդ
11,40 մլրդ
32,92 մլրդ
13,68 մլրդ
Operating expense
31,33 մլրդ
37,36 մլրդ
39,40 մլրդ
44,59 մլրդ
Total operating expenses
48,23 մլրդ
55,72 մլրդ
61,48 մլրդ
66,99 մլրդ
Operating income
13,00 մլրդ
12,92 մլրդ
14,39 մլրդ
13,18 մլրդ
Other non operating income
1,09 մլրդ
1,11 մլրդ
-3,70 մլրդ
1,06 մլրդ
EBT including unusual items
16,93 մլրդ
14,11 մլրդ
16,59 մլրդ
13,44 մլրդ
EBT excluding unusual items
17,27 մլրդ
14,96 մլրդ
20,88 մլրդ
13,63 մլրդ
Income tax expense
4,54 մլրդ
3,88 մլրդ
3,18 մլրդ
3,54 մլրդ
Effective tax rate
26,82%
27,52%
19,19%
26,35%
Other operating expenses
17,97 մլրդ
22,36 մլրդ
1,28 մլրդ
25,36 մլրդ
Net income
12,59 մլրդ
10,42 մլրդ
12,72 մլրդ
9,40 մլրդ
Net profit margin
20,55%
15,18%
16,77%
11,72%
Earnings per share
12,76
10,96
15,84
9,48
Interest and investment income
-
-
4,24 մլրդ
-
Interest expense
-1,01 մլրդ
-1,30 մլրդ
-491,00 մլն
-1,56 մլրդ
Net interest expenses
-1,01 մլրդ
-1,30 մլրդ
3,75 մլրդ
-1,56 մլրդ
Depreciation and amortization charges
3,02 մլրդ
3,60 մլրդ
5,08 մլրդ
5,55 մլրդ
EBITDA
15,70 մլրդ
15,10 մլրդ
17,74 մլրդ
16,53 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps